ArticleJCO global oncology2024

Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase- and ROS1 Fusion-Positive Non-Small Cell Lung Cancer in India.

Dharna Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.